New study offers novel treatment strategy for patients with colon cancer
(Boston University School of Medicine) Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. In a new study, researchers demonstrate for the first time that a previously uncharacterized protein is increased in colon cancer. The protein is immunoglobulin containing proline rich receptor-1 (IGPR-1) which was recently identified in the same laboratory as a cell adhesion molecule.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Boston University | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Laboratory Medicine | Study